A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

An NIH grant has been awarded to a group studying "crista" – inner-ear vestibular structures that are relatively under-studied, but are crucial for balance. The research group hopes that

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

The healthcare sector is always looking for new ways to optimize delivery, cut costs and offer more accurate results. AI has solutions to each of these challenges.

Given the complexity of cancer, it’s arguably unlikely that single molecules will work as clinically meaningful biomarkers for cancer. Today, biomarker discovery involves detecting patterns – characteristics or phenotypes that can be measured and monitored throughout a patient’s journey. Here, we look at two approaches being explored in this evolving field.

When developing diagnostic tests or evaluating results, it is important to understand how reliable those tests and therefore the results you are obtaining are. By using samples of known disease status, values such as sensitivity and specificity can be calculated that allow you to evaluate just that.

Running in parallel with advances in 3D cell culture is the growing use of human cells derived from induced pluripotent stem cells. Researchers are interested in testing drugs in the most physiologically relevant models possible, so it was only a matter of time before these two approaches converged – providing optimized systems for disease modeling and drug toxicity testing.

To improve cancer survival rates, pharma and biotech researchers must develop safe and effective therapies to treat not only primary tumors, but also metastatic growths and tumors that have acquired resistance.

In an age where advanced high-throughput-omic technologies allow for cheaper and faster screening of the genome, consumer genomics is becoming increasingly mainstream and a growing number of people are opting to purchase genetic tests for a variety of purposes, including personalized nutrition advice.